neuropharmacology
GLP-1 and NMDA Targeted Weight-Loss Drug Shows Promise
Health
Summary: Researchers have developed a novel weight-loss drug that combines GLP-1 with molecules targeting NMDA receptors in the brain. This “Trojan Horse” ...
Addiction Medication Offers New Hope for Long COVID Patients
Health
Summary: Researchers identified a potential treatment for long COVID by restoring the function of ion channels in immune cells using low-dose Naltrexone. ...
Risks of Antipsychotic Use in Dementia Patients
Health
Summary: A new study revealed significant risks associated with antipsychotic use in dementia patients, including increased chances of stroke, heart failure, pneumonia, ...
Treatment Relieves Chronic Lyme Disease’s Neurological Symptoms
Health
Summary: Fibroblast growth factor receptor inhibitors, commonly used in cancer treatment, could effectively reduce neurological symptoms in patients with post-treatment Lyme disease ...
Fecal Bacteria Transplant May Improve Parkinson’s Symptoms
Health
Summary: A new clinical trial revealed fecal microbiota transplantation (FMT) as a potential new treatment for Parkinson’s disease (PD), showing significant improvement ...
Immunotherapy Shows Promise as Alzheimer’s Treatment
Health
Summary: Researchers unveiled a novel approach to combat Alzheimer’s disease by activating microglia, the brain’s immune cells, to devour amyloid beta plaques, ...
Compound May Curb Alcohol Dependence
Health
Summary: The compound LY2444296, which blocks the kappa opioid receptor, significantly reduces alcohol consumption in animal models of alcohol dependence. This study ...
CaMKII Can Be Regulated to Mitigate Alzheimer’s
Health
Summary: The CaMKII protein, critical in brain and heart function, can be regulated to mitigate Alzheimer’s and heart conditions using three types ...
